Introduction
The orthopoxvirus family is a group of closely related viruses which are serologically difficult to distinguish and which have a highly conserved region in the centre of the genome (Esposito & Knight, 1985) . They are potential stimulators of the specific immune system (T and B cell-mediated) and of non-specific defence mechanisms (e.g. macrophage-, natural killer cell-, interferon-and interleukin-mediated). Active humoral and local cellular immunity can only be induced with live virus (Boulter et al., 1971) although non-specific mechanisms can be induced by inactivated virus too . However, orthopoxviruses show great differences in their biological characteristics such as host range, pathogenicity and virulence which correspond to deletions mainly on the left end of the genome Paez et al., 1987) . Structural proteins of Mr 54K, 37K, 34K, 32K, 25K, 20K, 17K, 16K, 14K and 13.8K which are localized in the outer envelope are believed to mediate early interactions responsible for virus entry into cells (Stern et al., 1976; Ichihashi & Oie, 1980 Rodriguez et al., 1985; Oie & Ichihashi, 1987) . So far, there is no agreement on the specific function of these proteins (Janeczko et al., 1987) which were all artificially prepared cleavage products. Their roles in virus replication, in the induction of specific immune responses and non-specific defence mechanisms are not fully understood. It has been shown that a 14K protein with its gen locus in the middle of the HindlII A DNA fragment plays an important role in virus-host cell interactions ). An alteration of this protein to 15-5K in some mutants is connected with decreased virulence . Little is presently known about the qualitative and quantitative distribution of these proteins in other orthopoxviruses. This is important, because the development of recombinant vaccinia viruses expressing foreign genes is in progress and may result in a new generation of live vaccines. But this also presents problems, because attenuated and genetically stable viruses are required (Edwards et al., 1988; Altenburger et al., 1989; Kaplan et al., 1989 ) and many of these recombinant virus strains are known to be 0000-9552 © 1990 SGM pathogenic to laboratory animals. On the other hand, the number of cases in which cowpox and cowpox-like strains cause localized skin lesions in man, pets and zoo animals is increasing (Mahnel, 1986; Bennett et al., 1989; Mahnel et al., 1989) . The possibility of naturally occurring recombination of the field strains with vaccinia virus cannot be excluded (R6sen et al., 1987) and infections of non-vaccinated or immunosuppressed persons seem to be possible (Becker et al., 1982) . Therefore, further characterizations of non-human orthopoxviruses by biological, genetic and immunological means are necessary. In this paper we describe the production of neutralizing anti-vaccinia virus monoclonal antibodies by a special immunization strategy. Virus epitopes were characterized in 16 orthopoxvirus strains under quantitatively defined conditions.
Methods
Viruses and cell cultures. Sixteen orthopoxvirus strains listed in Table  1 were propagated in primary embryonic chicken fibroblast cells and foetal bovine lung cells or in the permanent cell lines MA-104 (monkey kidney), RK-13 (rabbit kidney) and HeLa (human cervical carcinoma). The neurovirulent vaccinia virus strain Munich 1 (M1) was passaged six times in baby mouse brains to alter virulence. Infectivity titres were determined on Falcon 96-well microplates (Becton Dickinson); the TCID~o was calculated 7 days after incubation at 37 °C (Mayr et at., 1974) . For calculating the p.f.u., 24-well Linbro plates (Nunc) were used.
Virus propagation and purification. Cell cultures were infected with 1 TCIDs0/cell by adsorption for 60 min at 25 °C. Two to 3 days later c.p.e, had resulted in 90 to 100~ cytolysis and further purification followed as described by Joklik et al. (1962) with some modifications.
Infected cells were frozen (-70 °C), thawed (25 °C)End centrifuged at 12000g at 4°C for 90 min. The pellet was resuspended in 1 mM-Tris buffer pH 9.0 and an equal volume of Frigen (Frigen 113 TR-T; Hoechst) was added. After intensive sonication by a Branson sonicator and centrifugation at 2200g at 4 °C for 20 min, the supernatants containing the virus were collected. This stage was repeated twice by adding the same volume of Tris buffer to the remaining phase. The supernatants were pooled (semi-purified virus) and subsequently centrifuged at 80000g at 4 °C for 90 min through a 36~ (w/v) sucrose cushion. The virus pellets were resuspended in Tris buffer and left for 12 h before they were layered onto a preformed 20 to 60~ (w/w in Tris buffer) linear sucrose gradient and centrifuged at 50000g for 90 min. The visible virus band was collected by lateral puncture, pelleted at 80000g for 60 min, resuspended in Tris buffer and stored at -70 °C (purified virus). The protein contents were determined by the method of Lowry et al. (1951) .
Preparation of vaccinia virus envelopes and cores. The preparation was according to the procedure of Easterbrook (1966) . Purified modified vaccinia virus Ankara (MVA, 2000 ~tg) was resnspended in phosphatebuffered saline (PBS), dialysed and incubated with 1 ~ NP40 and 50 Ixl 2-mercaptoethanol for 60 min at 37 °C. Centrifugation followed in a Beckman rotor (SW60Ti) at 40000g for 45 rain through a 3-5 ml sucrose cushion (36~ w/v). The pellet (cores) was resuspended in PBS and the supernatant above the cushion (envelopes) was dialysed against PBS.
Production of immune sera. Six-to 8-week-old NMRI mice and BALB/c mice were immunized intraperitoneally (i.p.) with 0.1 ml/ animal of the MVA envelope preparation mixed with an equal volume of Freund's complete adjuvant. Two booster injections followed at 14 day intervals with Freund's incomplete adjuvant.
One rabbit (Chinchilla Bastard, 2.5 kg) was immunized subcutaneously (s.c.) with 175 rtg/animal of purified MVA. Three booster injections at 4 week intervals followed. MVA envelope or core preparations (0.1 ml) were injected s.c. into two other rabbits over a period of 3 months. Freund's complete and incomplete adjuvants were used for all immunizations. Production of monoclonal antibodies. Six-to 8-week-old female BALB/c mice were taken for all immunizations. The first group was immunized four times i.p. with 0.1 ml semi-purified live MVA over a 6 week period. The second group received three biweekly i.p. injections of 40 ~g purified MVA and a final booster injection where the antigen was applied i.p. and intravenously (i.v.). The third group was immunized four times at biweekly intervals with 80 pg MVA/animal. The immunization period was then prolonged to 12 weeks, but the amounts of virus applied were reduced to 60 and 40 pg/animal. All the antigens were.emulsified in complete and incomplete adjuvants. The final booster injection was free of adjuvant. A fourth group was infected with sublethal doses of the neurovirulent vaccinia virus Munich (M 1 ; non-purified) by i.p. application. Four weeks later mice were challenged with the same dose. Three days after the final booster the BALB/c spleen cells were harvested, mixed with the mouse myeloma cell line P3-X63Ag8.653 (Kearney et al., 1979) at a ratio of 3:1 and fused using 40% polyethylene glycol 1500 (Boehringer Mannheim) as described by K6hler & Milstein (1975) . The cells were suspended in HAT medium and dispensed into 96-well Falcon tissue culture plates (Becton Dickinson) or 24-well Linbro plates (Nunc). Two weeks later the supernatants were screened for antibody production by ELISA, pIaque-reduction tests (PRT) and haemagglutination inhibition tests (HI). Hybridomas secreting antibodies specific to vaccinia virus were cloned twice by limiting dilution, before serum-free cell culture supernatants and BALB/c ascitic fluids were produced.
Antibody screening tests. PRT and HI tests were performed by standard methods (Mayr et al., 1977) using 100p.f.u./0.05 ml of vaccinia virus MI and 5 x 105 MA-104 cells/ml, or 4 haemagglutinating units (HAU) of vaccinia virus Bern and a 0.5% suspension of chicken erythrocytes in PBS. For indirect ELISA, 96-well microplates (Immuno II, Nunc) were coated with 1 p.g/ml purified vaccinia virus in carbonate/bicarbonate buffer (pH 9.6; 100 ktl/well). Antibodies were incubated for 60 min at 37 °C. Binding was detected by peroxidaseconjugated anti-species IgG (Dakopatts) and made visible using 3,3',5,5'-tetramethylbenzidine (TMB; Serva) as indicator. The reaction was stopped 10 min later by 2 M-H2SO 4 and absorbance values were measured in a Titertek photometer (Flow Laboratories) at 450 nm. Extinctions >0-1 (double background values) were considered positive. Between each incubation step plates were washed five times with PBS containing 0-05 % Tween-20. Blocking of the microplates was not necessary, but all buffers contained 10% foetal calf serum. To estimate non-specific reactions, samples were tested in the same way on uncoated plates or on plates coated with 1 Itg/ml of mock-infected ceils.
Determination of the immunoglobulin subclasses and purification of the monoclonal antibodies. To determine immunoglobulin subclasses, serum-free hybridoma supernatants were diluted 1 : 5 in PBS, coated onto microtitre plates for 3 h at 37 °C and incubated for 30 min at 37 °C with dilutions of anti-mouse isotype-specific antisera produced in goats (Sigma). The substrate was TMB. IgG was isolated from ascitic fluids by affinity chromatography on Protein G-Sepharose columns (Pharmacia). The eluates were precipitated by addition of ammonium sulphate to 50% saturation and centrifuged for 30 min at 2200 g. The pellets were resuspended with PBS and extensively dialysed against this buffer. The protein contents of the samples were determined by the method of Lowry et aL (1951) .
Conjugation of antibodies with biotin.
Antibodies were biotinconjugated by standard methods as outlined by Guesdon et al. (1979) with Biotin-X-NHS dissolved in dimethyl formamide (Sigma).
Competition ELISA. Protein G-purified MAbs were dissolved in PBS to a protein concentration of 100 pg/ml and titrated in twofold steps on microplates (0.1 ml/well). The optimal working dilutions of the competing MAb-biotin conjugates as determined in chequerboard tests were added (0.1 ml/well). The antibody mixtures were transferred to ELISA plates coated with 1 pg/ml vaccinia virus MVA and incubated for 60 min at 37 °C. Peroxidase-conjugated avidin (Sigma), TMB and 2 M-H2SO 4 served as detecting reagents as described above. The reduction of the A4s o of the conjugated MAbs by the competing MAbs was calculated by the following formula : inhibition (%)=[1-(A450 MAb and MAb conjugate/Aas0 MAb conjugate)] x 100. The binding curves were plotted; minimal inhibitions of 50% were regarded as specific inhibition.
lmmunogold (IG) labelling technique. The procedure was similar to that of Murti & Webster (1986) . Purified MVA was adsorbed to Formvar-coated and carbon-vapourized 300-mesh grids. After washing in Tris-buffered saline (TBS) for 5 min, the grids were floated on TBS containing 3% gelatin for 60min, before serum-free cell culture supernatants of MAbs were added in optimal working dilutions. One h later the grids were floated on anti-mouse IgG-immunogold (particle size 5 nm, GAM 65/630, Janssen) and contrasted with phosphoric tungstic acid. Between each step the grids were washed thoroughly with TBS.
SDS-PAGE and immunoblotting.
Proteins of purified orthopoxviruses (10 ~tg/slot) were separated in vertical 12% polyacrylamide gels using the discontinuous, denaturing and reducing buffer system (Laemmli, 1970) . The protein bands were silver-stained by the method of Merril et al. (1981) , or transferred onto nitrocellulose membranes by Western blotting (Towbin et al., 1979) in a Transphor electroblotting chamber (Pharmacia). Detection followed standard techniques using monoclonal ascitic fluids or immune sera (1:150), horseradish peroxidase (HRP)-conjugated anti-IgG antisera and HRP colour developing reagent (Bio-Rad). The Mr of stained viral proteins were determined in a Beckman gel mate 1000 sonic digitizing system (Beckman) by comparison with Mr standards from 205K to 14.3K (Sigma).
Protection of BALB/c mice by passively transferred antibodies.
An infection model was established as outlined previously to test specific immune responses in white mice by challenge experiments with neurotropic vaccinia viruses. Protein G eluates of polyclonal and monoclonal anti-vaccinia virus antibodies were investigated for their ability to protect BALB/c mice after well defined i.p. and s.c. infections.
(i) l.p. challenge infection. Anti-vaccinia virus or control antibody preparations (0.1 ml) containing 100 ~tg purified protein were injected intracardially (i.card.) into narcotized [Rompun/Ketanest (50 mg/ml) 1:5; 0-05 ml/animal i.p.] BALB/c mice. Animals were challenged i.p. 24 h later with 4 LDso M1 (107.2 TCIDs0/ml).
(ii) S.c. challenge infection. Anti-vaccinia virus or control antibody preparations (0-2 ml) containing 100 ~tg purified protein were injected i.p. into BALB/c mice. Animals were challenged s.c. at the tail root 24 h later with 104 TCIDso/mouse of M1.
Results

Production and selection of neutralizhTg monoclonal antibodies
After five independent fusion experiments with hybridoma growth of 85 % to 100 %, supernatants of eight colonies were found secreting antibodies specific to vaccinia virus both in the ELISA and in the plaque reduction assay. No HI-positive colony was found. Two fusions with semi-purified and purified live vaccinia virus MVA followed a 6 week immunization period and gave a group of IgG2a MAbs with the same binding kinetics in the screening ELISA (3G4, 5B4, 7B10). Prolonging the immunization phase over a further 6 week period resulted in a group of IgG2b MAbs with lower ELISA affinity (2Cll, 2F4). Two fusions subsequent to the infection of BALB/c mice with sublethal doses of M1 led to the establishment of another group of IgG2a MAbs which also had lower extinctions in the ELISA (IB3, 1D6, 2D3). After cloning by limiting dilution, two positive subclones of each hybridoma colony were propagated in culture and in peritoneal cavities of BALB/c mice. Cell culture or ascitic fluids of all MAbs had ELISA binding and neutralizing activity, but for further investigations only Protein G-purified MAbs were used. In the ELISA, purified MAbs were adjusted to 1 ~tg/ml and titrated in twofold dilutions on microplates coated with 1 ~tg/ml of purified vaccinia virus MVA. This range seemed to be optimal for evaluation of the binding of the MAbs to their specific epitopes. MAbs within one group reacted with identical binding curves (Fig. 1 ). In the PRT the MAbs were adjusted to 10 ~tg/ml and then titrated against 100 p.f.u. of M 1 (MVA forms only microplaques). The neutralizing capacity of the IgG2a MAbs was within the same range, in spite of different reactivity in the ELISA. Plaque reduction of 50~ was achieved with 3-9 ng/0.05 ml (anti-MVA MAbs) and 5-9ng/0.05ml (anti-M1 MAbs) immunoglobulin, calculated from the mean values of the MAbs, whereas the neutralization effect of IgG2b MAbs was 100 times lower at 250 ng/0.05 ml.
Competition ELISA with conjugated MAbs
Purified MAbs were adjusted to 100 ~tg/ml and titrated against optimal dilutions of the competing biotinconjugated MAbs. An inhibition of at least 50~ of the conjugated MAb, measured by the reduced photometer extinction, served as an indication of binding to the same or to an adjacent or overlapping epitope (data not shown). Accordingly, all MAbs could be divided into three different epitope groups. The anti-MVA MAbs 3G5, 5B4 and 7B10 (IgG2a) bound to the same epRope as their inhibition curves were identical. This epitope was henceforth called 1 A. Another group of anti-MVA MAbs (2C11 and 2F4; IgG2b) was also uniform. Their epitope was called 1 B. MAbs of this group were inhibited by antibodies of epitope group 1 A to a 10-fold greater extent than vice versa. All anti-M1 MAbs (IB3, 1D6 and 2D3; IgG2a) could also be grouped together into the epitope group 2. Their inhibition curves were identical and their trends corresponded to those of epitope group I A. Epitope 2 had no relation to the two others. Table 2 summarizes the immunization scheme and shows the fusion experiments leading to the MAbs of different specificity.
Immunogold electron microscopy
Specific binding of the MAbs to the virus surface could be demonstrated well by electron microscopy (Fig. 2 ). Grids coated with purified MVA were incubated with the MAbs and then contrasted with IG. One MAb against equine herpesvirus type 1 (IgG2a, Meyer & Hfibert, 1988 ) was used as a negative control. The gold particles measured 5 nm. In the case of the anti-MVA MAb 5B4/2F2, which is directed against epitope 1 A, the IG (fine, dark dots) was bound evenly and very densely to the envelope of all the particles shown, far out on the surface filaments. The binding of IG by the anti-M1 MAb 1B3/1All, which is directed against epitope 2, took place on a quantitatively smaller scale; the point of binding was considerably closer to the virus particle. The anti-MVA MAb 2Cll/1B4 (epitope 1 B) also bound to the virus envelope. The position corresponded to that of MAb group 1 A, but the distribution of the gold particles was somewhat sparser.
Protein characterization of vaccinia virus
Vaccinia virus MVA was fractionated on 12~ SDSpolyacrylamide gels and subsequently transferred to nitrocellulose (0-22~tm, Schleicher & Schuell). The immunological detection of the transferred proteins was performed by standard procedures with the MAbs 5B4/2F2 (epitope 1 A), 2Cll/1B4 (epitope 1 B) and 1B3/1All (epitope 2) and with polyclonal rabbit and mouse hyperimmune sera against total virus, cores and envelopes which all had neutralizing activity. In Fig. 3 the results of the immunoblotting studies are summarized. After incubation with the polyclonal rabbit serum the prominent virus bands were localized at 86K, 75K, 73K, 67K, 61K, 57K, 36K, 32K, 30K, 25K, 21K, 20K, 17K, 16K, 14K and 12K. The rabbit immune serum against envelopes highlighted one intense band at 32K and a less intense band at 30K. The BALB/c immune serum against virus envelopes bound to the same bands with equal intensity. An additional band at 54K was highlighted whereas the NMRI mouse anti-envelope immune serum showed a strong reaction with one band at 21K, only a weak reaction with the band at 32K and no reaction with the band at 30K. All three sera were prepared with the same envelope fraction. A band at 36K which is at 37K in preparations from other vaccinia virus strains (data not shown) only reacted well with a rabbit serum against the total virus. The rabbit anti-core serum detected two intense bands at 61K and 57K as well as three other proteins of higher Mr at 86K, 73K, and 67K which did not react with the anti-envelope sera. It also recognized two proteins at 32K and 30K and a protein at 14K with low intensity. The 30K protein was also stained after incubation with the MAb 5B4/2F2 (epitope 1 A). This MAb also identified to a lesser degree a 16K and a 14K protein. The MAbs of the epitope group 1 B also marked these two proteins. The 30K protein, however, was hardly visible. MAbs of the epitope group 2 reacted intensely with the 16K protein and weakly with the 14K protein, and only a faint reaction with the 30K protein was seen. 
Passive protection of white mice by mono-and polyclonal antibodies
One-hundred lag purified MAbs and 10-fold dilutions of polyclonal immune sera as listed in Table 3 were i.card. injected into narcotized 6-week-old BALB/c mice.
Challenge infections 24 h later were carried out by i.p. application of 4 LD5o (equivalent to 10 7.2 TCIDso) or s.c. application of 10 4 TCIDso of M1 at the tail root. A hyperimmune serum specific for vaccinia virus and a combination of the two distinct MAbs 5B4/2F2 and 1B3/1All protected the mice without any clinical symptoms, whereas the MAbs alone could not adequately prevent illness but protected from death. Neither the epitope 1 B MAb 2C11/1B4 nor the controls showed any protection. No protection could be achieved against an s.c. challenge. All mice became ill with typical pock lesions, but none of them died and they all recovered within 3 to 4 weeks post-infection (p.i.). 
Serological relatedness of different orthopoxvirus strains in ELISA
Sixteen immunologically closely related, but biologically very distinct orthopoxvirus strains were investigated for characteristics indicating cross-reactivities within the three different epitopes. All tests were performed in duplicate as described. Purified MAbs were adjusted to 1 gg/ml and titrated on microplates coated with 1 gg/ml purified viruses. Evaluation of the epitope-antibody interaction kinetics (photometer extinction, protein concentration) was the basis for comparing the individual strains. For these assay conditions we assumed that the binding of the antibodies recognizing epitopes 1 A and 2 followed Michaelis-Menten kinetics. Binding curves showed a sigmoid course for most of the strains. From linear regression we calculated Lineweaver-Burk diagrams and determined the theoretical Vmax (maximal extinction) and the Michaelis-Menten constants (Km), the latter representing the MAb concentration (ng/ml) at ½ Vmax which gives information about the affinity of a MAb for its epitope (van Heyningen et al., 1983) . Photometer extinctions <0-1 could not be included in the regression analysis, as these are too low and imprecise and made it impossible to calculate the Vmax. MAb combination 0/6 -0/6 9 MAb 2C 11/1 B4 IgG2b 9/9 Severe 9/9 6 BEC~ immune serum 6/6 Severe 6/6 9 MAb EHV-I:~ IgG2a 9/9 Severe 9/9 9 PBS 9/9 Severe 9/9 8,9,10 7,10,11 6,7 6,7 * Challenge infection with vaccinia virus M1 i.p. (4 LDs0/mouse ). 1" Clinical symptoms (number of diseased animals/total number) and lethality (number of dead animals/total number). J/BEC, Bovine enteric coronavirus; EHV-1, equine herpesvirus 1. showed maximal reactions with Vma x of 1"17 to 1"5 and Km of 386 to 628. Lower photometer extinctions (0.91 and 0.94) and affinities (742 and 815) were found for vaccinia virus Bern and TT. Cowpox virus KR-2 Brighton (1-08; 730) and OPV/85 (0.83; 624) were also in this range, followed by elephantpox, buffalopox and camelpox viruses (0.39 to 0.68; 797 to 830). MAbs to epitope 2 had the highest affinities for strains MVA, IHD-J and Bern; however, no typical vaccinia virus group was seen. Monkeypox and rabbitpox viruses possess approximately the same amount of this epitope, followed by the vaccinia virus R 325. The Km values ranged from 83 to 148, Vma x values from 1"3 to 1-5. Cowpox virus KR-2 Brighton had a Km in this range (109), but a lower Vmax (0"98). In particular, with vaccinia virus Elstree, the neurovirulent vaccinia viruses, Levaditi and M1, Km values differed to a greater extent (192 to 289) than the Vm~x values (1.25 to 1.37). The recombinant vaccinia virus TT, BP-1, CP1 and OPV/85 had lower Vmax (0"65 to 0.8) and Km values (186 to 335), whereas with EP-1 only a very low affinity of 726 was reached.
Serological relatedness in the plaque reduction test
Thirteen of the orthopoxvirus strains were also investigated in the PRT on MA-104 cells with MAbs against epitopes 1 A and 2 which were completely different from each other and seemed to be more important than epitope 1 B. MVA (which forms microplaques on CEF cells), vaccinia TT and camelpox viruses were omitted. The initial MAb concentration was 10000 ng/ml and in Table 5 the values giving 50~ plaque reduction are shown. For each virus strain the median values of two MAbs recognizing the same epitope are presented. The epitopes 1 A and 2 were of approximately similar importance for virus neutralization in the vaccinia virus strains M1, Bern, and buffalopox virus. The MAb concentrations for 50~ neutralization ranged from 78 to 313 ng/ml. In vaccinia viruses Elstree and R 325 and the neurovirulent vaccinia virus Levaditi, epitope 1 A was dominant. The importance of this epitope for neutralization rapidly decreases in cowpox and elephantpox viruses (1250 and 1850) compared with epitope 2 which is neutralized in a narrower range and fairly uniformly in all the strains tested. OPV/85 could not be neutralized by MAbs binding to epitope 1 A and the reaction of MAbs against epitope 2 also showed a wider deviation up to 1250 ng/ml. IHD-J and rabbitpox virus both needed more IgG for neutralization of epitope 1 A (469 and 625) and epitope 2 (313 and 625) than had been expected, given their high affinities in the ELISA.
Discussion
Neutralizing MAbs against three distinct epitopes of vaccinia virus called 1 A, 1 B and 2 were produced by a special immunization strategy. MAbs binding to the epitope 1 A were obtained from BALB/c mice immunized with semi-purified or purified vaccinia virus MVA over 6 weeks. A prolonged immunization period with more purified virus led to MAbs binding to epitope 1 B. Antibodies to epitope 2 resulted from mice which were sublethaUy infected with non-purified vaccinia virus M1. The epitope 1 A was the most dominant in the ELISA reaction and lower extinction values were obtained for the two others. In competition ELISAs, MAbs binding to epitopes 1 A and 1 B influenced each other. MAbs to 1 A inhibited 1 B MAbs to a 10-fold greater extent than vice versa. MAbs to epitope 2 were a uniform group with no influence on each other. It is significant that the special method of immunization always led to a uniform group of MAbs. MAbs binding to the distinct epitopes 1 A and 2 had almost the same 50% neutralization capacity at 3-9 and 5.9 ng/0-05 ml. From these data it was possible to calculate that about 300 and 170 infectious virus particles were neutralized by 1 ng IgG2a. The 50% value for 1 B MAbs lay at 250 ng/0.05 ml, showing that four infectious particles were neutralized by 1 ng IgG2b. The maximal reduction that could be achieved by a single MAb was 95%. The tissue culture-propagated vaccinia virus to which the MAbs bind is largely cell-associated. However, a small proportion of mature virus particles acquire an additional envelope at intracellular membranes. These extracellular virus particles differ antigenically and are responsible for rapid virus dissemination, especially in infected individuals (Payne, 1978 (Payne, , 1980 . Therefore, it was important to investigate whether the MAbs also were able to prevent an infection in vivo. MAbs to epitopes 1 A and 2 were able to protect mice from a lethal i.p. vaccinia virus infection. No clinical symptoms appeared when both MAbs were injected together. MAbs specific for epitope 1 B had no protective effect. Immunogold staining demonstrated that all MAbs bound to the virus envelope. Epitopes 1 A and B were located far out on the surface tubules, whereas epitope 2 lay nearer the virus particle. The immunoblots which demonstrated that all the epitopes were located on three proteins of Mr 30K, 16K and 14K gave more accurate information. MAbs to epitope 1 A marked mainly the 30K band, 1 B MAbs bound to the 16K and the 14K bands and MAbs to epitope 2 intensely stained the 16K band. In view of this, one can conclude that the 16K and 14K proteins are related in some way to the 30K band. The MAb epitopes seem to be located on common or different components on the surface tubules which split Monoclonal antibodies to orthopoxviruses 2349 into subunits of different Mr during the degradation of the virus for electrophoresis. Rodriguez et al. (1985) immunized mice with u.v.-inactivated vaccinia virus and isolated three neutralizing MAbs binding to different epitopes of a single 14K protein, but only two MAbs showed a convincing plaque reduction of 50% with 10 -2 and 10 -4 dilutions of ascitic fluids. Oie & Ichihashi (1987) described neutralizing MAbs binding to virus proteins at 54K, 34K, 32K, 29K and 25K to 17K which could be extracted from the envelope by NP40 and mercaptoethanol (Ichihashi & Oie, 1980; Oie & Ichihashi, 1981) . Stern & Dales (1976) isolated a 58K surface tubule protein that induced cell--cell fusion and neutralizing antibodies in rabbit sera which inhibited cellular protein synthesis (Mbuy et al., 1982) and which was identical to the 54K protein of Oie & Ichihashi (1981) . It is difficult to compare M, data for apparently homologous polypeptides from several authors, because different techniques were used which led to slight variations in the values. Our rabbit and mouse immune sera against viral envelopes also had neutralizing potency and bound to the 54K, 32K, 30K and 21K proteins but not in the same way as the MAbs to the 16K and 14K envelope proteins. Proteins at 87K, 73K, 67K, 61K and 57K were found only in the core corresponding to the major core proteins described by Essani & Dales (1979) and Oie & Ichihashi (1981) . Additionally, three proteins at 32K, 30K and 14K were found; the latter may be identical to a 13.8K core protein (Ichihashi et al., 1982) , but it is well known that incubation of vaccinia virus with detergents does not completely remove tubules from the cores (Mbuy et al., 1982) which would result in tubule-specific antibodies after immunization with such a preparation. Orthopoxviruses have .been standardized mainly by biological characteristics and DNA analysis. Quantitative serological differentiation by polyclonal antibodies is difficult and, because of their close relationships, not very helpful (Mahnel et al., 1974; Wittek, 1982; Esposito & Knight, 1985) . ELISAs are well suited to evaluating qualitative and quantitative epitope characteristics in virus strains. The absolute number of particles, as well as concentrations and affinities of the antibodies to their specific epitopes, are responsible for the scale of the reaction. When purified reagents are used, interfering influences are as small as possible. A biological assay such as the PRT allows measurement of one of the most important roles of antibodies, namely neutralization, and many serological classifications are based on the results of this test. Standardized conditions are also ensured (protein content of the MAbs, 100 p.f.u, of the virus), but individual characteristics of a virus play a greater role than in binding tests. A correlation of the results of these different tests is difficult. However, in is made to demonstrate the immunological relationships of the orthopoxviruses as a three-dimensional model. The coordinates were determined by the photometer extinctions and Km values of the MAbs in the ELISAs, as well as by the concentrations giving 50% plaque reduction. With regard to the epitope l A, the vaccinia viruses formed a very closely related group. If the protein content for 50% plaque reduction is contrasted with the Km values, it is seen that high antibody affinities also led to a higher neutralizing effect. If the Km increases, the affinity and the ability to neutralize usually decrease. However, this does not always occur and the potency for neutralization of a MAb cannot be precalculated from its Km value. IHD-J and rabbitpox virus, which have a high multiplicity rate, demonstrated a special plaque formation called 'comet formation' (Appleyard et al., 197l; Payne, 1980) . It consists of primary plaques surrounded by a multitude of secondary plaques. This phenomenon was responsible for the neutralization being weaker than in other vaccinia virus strains, although the MAbs had equally good binding kinetics in the ELISA. In spite of a lower Vmax and an equally low Km in the ELISA, buffalopox virus was more closely related to the vaccinia virus strains than to cowpox and elephantpox virus, because the epitope was neutralized with a smaller amount of IgG. This coincides with several reports from other investigators who regarded isolates from buffaloes as closely related to vaccinia viruses (Baxby & Hill, 1971) , whereas in the case of elephantpox virus some isolates seem to be related more closely to cowpox virus and others to vaccinia viruses (Mahnel, 1974) admittedly with separate individual characteristics (Baxby & Ghaboosi, 1977) . For epitope 2 the orthopoxviruses appeared to form a group in which strain-and species-specific characteristics could barely be seen. With this epitope even MAbs with a low affinity led to the same neutralization effect, and this could be demonstrated especially for elephantpox virus.
The status of OPV/85, however, remained obscure. It was isolated from a non-vaccinated 6-year-old girl in 1985 (Nasemann et al., 1987) in whom it caused a localized skin lesion. It was classified as a cowpox-like virus by its biological behaviour (Mahnel, 1986) , the HindlII and SmaI cleavage patterns of the DNA were virtually identical to those of an elephantpox virus isolate, but it cannot be ruled out that it is a recombinant of unknown origin (Rdsen et al., 1987) . MAbs against epitope 1 A had the lowest extinction in the ELISA with this strain, but a similar Km to cowpox KR-2 Brighton or buffalopox viruses; however they were not able to neutralize 100 p.f.u, of the virus with concentrations up to 10 ~tg/ml. Neutralization by epitope 2 was also poorer than in the other strains.
Taking all the data together, it can clearly be seen that the three neutralizing epitopes were present in all orthopoxviruses tested, with the exceptions of monkeypox virus which does not possess epitopes 1 A and 1 B and ectromelia virus which lacked all three epitopes. These viruses resemble most of the known orthopoxvirus species as well as horsepox, variola major and minor viruses. Strain-and species-specific characteristics seemed to be responsible for quantitative variations of the MAb reactivities, but the data were not suitable for differentiating and classifying orthopoxviruses. However, we have indications that rapid immunological differentiation might be possible with a panel of eight or nine different neutralizing and non-neutralizing MAbs raised against vaccinia, cowpox, monkeypox and ectromelia viruses (unpublished results). Ichihashi & Oie (1988) have shown with 99 MAbs recognizing separate epitopes that they are widely distributed in orthopoxviruses and only a small number of type-specific epitopes were found. Species specificity seemed to be due to a total configuration of epitopes. In our investigations no connection between the presence of an epitope and noticeable differences in the biological behaviour could be found. The highly attenuated MVA (over 500 serial passages in CEF cells) which has three major DNA deletions totalling about 8 kb on HindIII fragments B, C, M and N (Altenburger et al., 1989) reacted in the ELISA just as well as reference strains like Elstree or other strains. It multiplies only in primary CEF cell culture with optimal yield and with microplaques, and has lost its pathogenicity to animals and more than 120000 human vaccinees (Mayr & Danner, 1979) . , and Paez et al. (1987) also established and investigated attenuated vaccinia virus strains. In addition to reduced virulence and preserved immunogenicity, they found alterations of the molecular masses and isoelectric points of several structural proteins. Most important was the increase in size of a 14K protein by up to 3K. In our investigations with vaccinia viruses the strains Bern and TT showed remarkably low reactions with MAbs binding to the epitope 1 B, whereas the strains Elstree, TT, Levaditi and M1 had noticeably lower affinities to epitope 2. These epitopes were mainly localized on the 16K and 14K proteins.
